Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Norfloxacin Market Price & Analysis > Featured News - Norfloxacin > Zhejiang Dongya Pharmaceutical's nafloxacin bulk drug obtained the Korean bulk drug registration certificate
— Share —

Zhejiang Dongya Pharmaceutical's nafloxacin bulk drug obtained the Korean bulk drug registration certificate

healthoo 2021-10-28
Recently, Zhejiang East Asia Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "East Asia Pharmaceutical") received the "Raw Material Drug Registration Certificate" issued by the Korean Ministry of Food an

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.